Patents Assigned to Janssen Pharaceutica, N.V.
  • Substituted fused heterocyclic C-glycosides
    Patent number: 7094763
    Abstract: This invention relates to substituted fused heterocyclic C-glycosides, compositions containing them, and methods of using them, for example, for the treatment or prophylaxis of diabetes and Syndrome X.
    Type: Grant
    Filed: July 30, 2004
    Date of Patent: August 22, 2006
    Assignee: Janssen Pharaceutica, N.V.
    Inventors: Philip Rybczynski, Maud Urbanski, Xiaoyan Zhang